Retractable Technologies (RVP) Competitors $0.97 -0.06 (-5.37%) Closing price 10/10/2025 03:59 PM EasternExtended Trading$0.98 +0.01 (+0.65%) As of 10/10/2025 06:54 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock RVP vs. PDEX, APYX, OBIO, NSPR, FONR, NTRB, VANI, PSTV, EDAP, and ZJYLShould you be buying Retractable Technologies stock or one of its competitors? The main competitors of Retractable Technologies include Pro-Dex (PDEX), Apyx Medical (APYX), Orchestra BioMed (OBIO), InspireMD (NSPR), Fonar (FONR), Nutriband (NTRB), Vivani Medical (VANI), Plus Therapeutics (PSTV), Edap Tms (EDAP), and Jin Medical International (ZJYL). These companies are all part of the "medical equipment" industry. Retractable Technologies vs. Its Competitors Pro-Dex Apyx Medical Orchestra BioMed InspireMD Fonar Nutriband Vivani Medical Plus Therapeutics Edap Tms Jin Medical International Retractable Technologies (NYSE:RVP) and Pro-Dex (NASDAQ:PDEX) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their valuation, dividends, risk, institutional ownership, analyst recommendations, media sentiment, earnings and profitability. Do analysts prefer RVP or PDEX? Pro-Dex has a consensus price target of $56.00, suggesting a potential upside of 68.02%. Given Pro-Dex's stronger consensus rating and higher possible upside, analysts plainly believe Pro-Dex is more favorable than Retractable Technologies.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Retractable Technologies 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Pro-Dex 0 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.50 Which has stronger valuation and earnings, RVP or PDEX? Pro-Dex has higher revenue and earnings than Retractable Technologies. Retractable Technologies is trading at a lower price-to-earnings ratio than Pro-Dex, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioRetractable Technologies$38.16M0.76-$7.01M-$0.29-3.36Pro-Dex$66.59M1.64$8.98M$2.7012.34 Does the media refer more to RVP or PDEX? In the previous week, Pro-Dex had 2 more articles in the media than Retractable Technologies. MarketBeat recorded 4 mentions for Pro-Dex and 2 mentions for Retractable Technologies. Retractable Technologies' average media sentiment score of 1.45 beat Pro-Dex's score of 0.79 indicating that Retractable Technologies is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Retractable Technologies 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Pro-Dex 0 Very Positive mention(s) 2 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do insiders and institutionals believe in RVP or PDEX? 7.6% of Retractable Technologies shares are held by institutional investors. Comparatively, 15.3% of Pro-Dex shares are held by institutional investors. 57.1% of Retractable Technologies shares are held by company insiders. Comparatively, 47.5% of Pro-Dex shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term. Is RVP or PDEX more profitable? Pro-Dex has a net margin of 13.48% compared to Retractable Technologies' net margin of -41.11%. Pro-Dex's return on equity of 26.67% beat Retractable Technologies' return on equity.Company Net Margins Return on Equity Return on Assets Retractable Technologies-41.11% -17.15% -9.33% Pro-Dex 13.48%26.67%14.95% Which has more volatility and risk, RVP or PDEX? Retractable Technologies has a beta of 1.45, suggesting that its stock price is 45% more volatile than the S&P 500. Comparatively, Pro-Dex has a beta of -0.11, suggesting that its stock price is 111% less volatile than the S&P 500. SummaryPro-Dex beats Retractable Technologies on 13 of the 16 factors compared between the two stocks. Get Retractable Technologies News Delivered to You Automatically Sign up to receive the latest news and ratings for RVP and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding RVP and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart RVP vs. The Competition Export to ExcelMetricRetractable TechnologiesSurgical & medical instruments IndustryMedical SectorNYSE ExchangeMarket Cap$29.18M$72.02M$6.10B$21.89BDividend YieldN/AN/A5.67%3.61%P/E Ratio-1.809.8686.0528.83Price / Sales0.7640.03612.1482.97Price / Cash48.2518.4138.5024.17Price / Book0.2917.1212.754.51Net Income-$7.01M-$27.88M$3.31B$1.01B7 Day Performance13.60%0.22%0.80%-3.53%1 Month Performance20.18%1.53%6.21%-1.95%1 Year Performance28.42%58.67%80.34%10.26% Retractable Technologies Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)RVPRetractable Technologies1.9941 of 5 stars$0.97-5.4%N/A+29.1%$29.18M$38.16M-1.80240News CoveragePositive NewsPDEXPro-Dex3.006 of 5 stars$33.36-1.4%$56.00+67.9%+14.4%$108.95M$66.59M12.37140News CoverageAnalyst ForecastAPYXApyx Medical1.6362 of 5 stars$2.75-5.0%N/A+147.5%$104.57M$48.10M-6.14270News CoverageAnalyst ForecastOBIOOrchestra BioMed3.1083 of 5 stars$2.67-3.8%$13.50+406.6%-34.5%$102.98M$2.64M-1.464News CoverageAnalyst ForecastNSPRInspireMD2.8657 of 5 stars$2.41-3.6%$4.50+86.7%-9.3%$100.59M$7.07M-3.2150FONRFonar1.5273 of 5 stars$16.03+0.2%N/A+0.7%$99.36M$104.35M13.03480NTRBNutriband2.2035 of 5 stars$7.56-3.6%$13.00+72.0%+5.8%$90.95M$2.14M-2.6310News CoverageAnalyst ForecastGap DownVANIVivani Medical2.7328 of 5 stars$1.40-1.1%$4.00+186.7%+23.4%$82.64MN/A-3.1020PSTVPlus Therapeutics3.7223 of 5 stars$0.83-6.5%$8.00+861.5%-46.3%$82.59MN/A-0.3720Analyst ForecastGap DownEDAPEdap Tms2.943 of 5 stars$2.19-4.4%$8.50+288.1%-21.0%$81.88M$69.18M-3.59230Analyst ForecastZJYLJin Medical InternationalN/A$0.51-10.5%N/A-83.3%$79.53M$22.83M0.00245Analyst ForecastGap UpHigh Trading Volume Related Companies and Tools Related Companies PDEX Competitors APYX Competitors OBIO Competitors NSPR Competitors FONR Competitors NTRB Competitors VANI Competitors PSTV Competitors EDAP Competitors ZJYL Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:RVP) was last updated on 10/11/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | Sponsored2013 miner reveals his trading systemWhile everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | SponsoredForget AI, This Will Be the Next Big Tech BreakthroughAfter picking Nvidia in 2016, before it jumped 27,000%... Jeff Brown is back with what he believes will be ...Brownstone Research | SponsoredFront-Run Buffett's Shocking Gold MoveA Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredBuy UBER immediatelyBULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredIf You Keep Cash In A U.S. Bank Account… Read This NOWThe Treasury Department just issued a stunning warning: U.S. banks could lose up to $6.6 trillion of custom...Banyan Hill Publishing | SponsoredGold to $27,533?This week, U.S. gold reserves hit an unprecedented $1 TRILLION in value... And it's sparking urgent chatter...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Retractable Technologies, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Retractable Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
